Recent news

The ability to accurately count seizures is important to provide the best care for each individual with epilepsy. Together with UCB Pharma, Byteflies has been paving the way to more accurate seizure counting outside the hospital. EpiCare@Home provides a powerful and unobtrusive remote seizure monitoring device and neurologist dashboard.

CovidCare@Home demonstrates the power of Byteflies Care@Home. In just three months, 30 Belgian hospitals were enrolled and we worked with RIZIV/INAMI to secure reimbursement. By December 2021, more than 1000 patients had been successfully sent home with CovidCare@Home, accounting for more than 22,500 remote measurements.